Myriad Genetics | MYGN - Ordinary Share Capital


Myriad Genetics reported $93.5M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Agilent USD 282.7M 358K Dec/2025
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Bio-Rad Laboratories USD 26.97M 90K Sep/2025
Bruker USD 151.94M 225K Dec/2025
Danaher USD 706.9M 600K Dec/2025
Hologic USD 222.57M 350K Sep/2025
Illumina USD 152.8M 900K Dec/2025
J&J USD 2.41B 584K Sep/2025
Mettler Toledo International USD 20.43M 170.6K Dec/2025
Myriad Genetics USD 93.5M 400K Dec/2025
OraSure Technologies USD 70.39M 1.87M Dec/2025
Pacific Biosciences Of California USD 301.96M 103K Dec/2025
Quest Diagnostics USD 110M 1000K Dec/2025
Quidel USD 67.9M 200K Sep/2025
Repligen USD 56.32M 42K Dec/2025
Revvity USD 113.38M 2.7M Dec/2025
Standard Biotools USD 386.38M 2.77M Dec/2025
Thermo Fisher Scientific USD 375.71M 1.9M Dec/2025
Veracyte USD 79.05M 377K Dec/2025
Waters USD 98.08M 38.55M Dec/2025